Investing in equity markets is a reliable, wealth-growing strategy. In the past 33 years, the S 500's average annual return is about 10.6%. It's hard to find a return much better than that elsewhere.

Some individual stocks have performed even better, though. Take Vertex Pharmaceuticals (NASDAQ: VRTX), a leading biotech company whose average annual return since its 1991 initial public offering (IPO) is 15.1%. The drugmaker has grown by 10,310%.

It is an impressive performance, but Vertex still has plenty of growth ahead of it, and the stock looks like a solid buy-and-hold-forever pick. Here is why.

Continue reading

Source Fool.com